Stock A006620 DONGKOO BIO & PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company DongKoo Bio & Pharma Co., Ltd.

Equities

A006620

KR7006620009

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
7,810 KRW +20.34% Intraday chart for DongKoo Bio & Pharma Co., Ltd. +24.17% +37.99%
02/05 Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on November 2, 2023. CI
02/05 Tranche Update on DongKoo Bio & Pharma Co., Ltd.'s Equity Buyback Plan announced on November 2, 2023. CI

Business Summary

Dongkoo Bio&Pharma Co.,Ltd. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The major products include antihistamines, topical steroids, therapeutic agents for prostatitis, treatments for benign prostatic hyperplasia, atherosclerotic agents, and antibiotics, among others. The Company is involved in contract manufacturing organization business. It manufactures and sells therapeutic for osteoporosis, antiviral agents, erectile dysfunction treatments, hepatic disease agents; painkillers; gum treatments. In addition, the Company is engaged in the manufacturing and sale of medical devices and cosmetics. The Company distributes its products within the domestic market and to overseas markets, including America and Europe.

Number of employees: 355

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medicine
99.6 %
194,434 99.7 % 214,877 99.6 % +10.51%
Connection Adjustment
-1.2 %
-1,275 -0.7 % -2,517 -1.2 % +97.43%
Marketing Agency
1.1 %
1,119 0.6 % 2,360 1.1 % +110.99%
Banking Service
0.4 %
710 0.4 % 966 0.4 % +36.10%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
98.6 %
189,466 97.4 % 212,140 98.6 % +11.97%
Overseas
1.4 %
5,030 2.6 % 2,924 1.4 % -41.86%

Managers

Managers TitleAgeSince
Yong-Joon Cho CEO
 Chief Executive Officer 58 -
Yoon-Sik Kim CTO
 Chief Tech/Sci/R&D Officer 54 -
Yong-Woo Kim BRD
 Director/Board Member 50 -
Do-Hyung Kim BRD
 Director/Board Member 51 -
Byung-Chan Jung SAM
 Sales & Marketing 51 -

Members of the board

Members of the board TitleAgeSince
Jae-Hong Park BRD
 Director/Board Member 61 -
Yong-Joon Cho CEO
 Chief Executive Officer 58 -
In-Su Mun BRD
 Director/Board Member 59 -
Do-Hyung Kim BRD
 Director/Board Member 51 -
Yong-Woo Kim BRD
 Director/Board Member 50 -
Sung-Hwa Ha BRD
 Director/Board Member 50 -
Yeon-Ju Lee BRD
 Director/Board Member 48 -
Kyu-Jin Choi BRD
 Director/Board Member 53 -
Eun-Ok Choi BRD
 Director/Board Member 57 -
Yo-Chan Park BRD
 Director/Board Member 62 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 28,464,992 15,539,751 ( 54.59 %) 841,443 ( 2.956 %) 54.59 %

Shareholders

NameEquities%Valuation
Yong-Joon Cho
28.35 %
8,068,463 28.35 % 39 M ₩
Kyoung-Ok Lee
11.32 %
3,222,960 11.32 % 16 M ₩
DONGKOO BIO & PHARMA CO., LTD.
2.956 %
841,443 2.956 % 4 M ₩
Do-Hyung Kim
1.347 %
383,310 1.347 % 2 M ₩
DongKoo Bio & Pharm Co. Ltd. ESOA
0.4709 %
134,047 0.4709 % 647 879 ₩
Ho-yoon Cho
0.4689 %
133,460 0.4689 % 645 042 ₩
Eun-sook Cho
0.2551 %
72,600 0.2551 % 350 892 ₩
Eun-kyung Cho
0.1931 %
54,960 0.1931 % 265 634 ₩
Dimensional Fund Advisors Ltd.
0.0161 %
4,581 0.0161 % 22 141 ₩
DFA Australia Ltd.
0.001813 %
516 0.001813 % 2 494 ₩

Holdings

NameEquities%Valuation
DONGKOO BIO & PHARMA CO., LTD.
2.96%
 841,443 2.96% 4,066,879 $
TS NEXGEN CO., LTD.
1.99%
 2,292,738 1.99% 1,456,508 $
GENOME & COMPANY
0.67%
 100,000 0.67% 499,964 $

Company contact information

DongKoo Bio & Pharm Co. Ltd.

14th Floor, M State Building 114 Beobwon-ro

05854, Seoul

+

http://www.dongkoo.co.kr
address DongKoo Bio & Pharma Co., Ltd.(A006620)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
DONGKOO BIO & PHARMA CO., LTD. Stock DongKoo Bio & Pharma Co., Ltd.
+37.99% 16Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 58TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+7.39% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 21TCr
NOVARTIS AG Stock Novartis AG
+10.02% 21TCr
AMGEN INC. Stock Amgen Inc.
+8.49% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A006620 Stock
  4. Company DongKoo Bio & Pharma Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW